Jun Xue

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jinfeng Zhang, Yongqiang Yang, Zilong Wu, Sisi Zhang, Zhenyu Lin, Hongli Liu, Jianli Hu, Tao Zhang, Jing Tang, Jun Xue
Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial. BMJ open 14 (6) (2024)
Jinfeng Zhang, Yongqiang Yang, Zilong Wu, Sisi Zhang, Zhenyu Lin, Hongli Liu, Jianli Hu, Tao Zhang, Jing Tang, Jun Xue
Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial. BMJ open 14 (6) (2024)
Jinfeng Zhang, Yongqiang Yang, Zilong Wu, Sisi Zhang, Zhenyu Lin, Hongli Liu, Jianli Hu, Tao Zhang, Jing Tang, Jun Xue
Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial. BMJ open 14 (6) (2024)
Jinfeng Zhang, Yongqiang Yang, Zilong Wu, Sisi Zhang, Zhenyu Lin, Hongli Liu, Jianli Hu, Tao Zhang, Jing Tang, Jun Xue
Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial. BMJ open 14 (6) (2024)
Yue Hu, Min Zhou, Jing Tang, Shuang Li, Hongli Liu, Jian-Li Hu, Hong Ma, Jun-Li Liu, Tingting Qin, Xiongjie Yu, Yongshun Chen, Jin Peng, Yanmei Zou, Tao Zhang, Jun Xue
Efficacy and safety of stereotactic body radiotherapy combined with Camrelizumab and Apatinib in hepatocellular carcinoma patients with portal vein tumor thrombus. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)